SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Durect (DRRX)

DRRX RSS Feed
Add DRRX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 8/14/2017 2:19:15 PM - Followers: 73 - Board type: Free - Posts Today: 0

http://www.durect.com/

http://finance.yahoo.com/q/ks?s=DRRX

DURECT Corporation, a specialty pharmaceutical company, focuses on the development of pharmaceutical products for pain, central nervous system, disorders, cardiovascular disease, and other chronic diseases based on its proprietary drug formulations and delivery platform technologies. The company?s products include POSIDUR, a release formulation of bupivacaine under Phase IIb clinical trial, which is used for the treatment of post-surgical pain; and ELADUR, a transdermal bupivacaine patch under Phase IIb clinical trial that provides continuous delivery of bupivacaine for up to three days from a single application, as well as is used for the treatment of pain associated with post-herpetic neuralgia. It also offers Remoxy, an oral oxycodone gelatin capsule under development with pain therapeutics; and TRANSDUR-Sufentanil, a proprietary transdermal sufentanil patch under development, which provides continuous delivery of sufentanil for a period of up to seven days from a single application. In addition, the company offers CHRONOGESIC (sufentanil), a pain therapy system; and ALZET, the miniature implantable osmotic pumps and accessories for experimental research in mice, rats, and other laboratory animals, as well as conducts research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies. Further, it designs, develops, and manufactures various biodegradable polymers based on lactide, glycolide, and caprolactone under the LACTEL brand for pharmaceutical and medical device clients for use as raw materials in their products. The company has collaboration agreements with Alpharma Ireland Limited; Nycomed Danmark, APS; Pain Therapeutics, Inc.; Endo Pharmaceuticals Inc; Voyager Pharmaceutical Corporation; ALZA Corporation; EpiCept Corporation; and NeuroSystec Corporation. DURECT Corporation was founded in 1998 and is based in Cupertino, CA.

DRRX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
DRRX News: Securities Registration: Employee Benefit Plan (s-8) 08/09/2017 04:28:34 PM
DRRX News: Quarterly Report (10-q) 08/09/2017 04:22:28 PM
DRRX News: Current Report Filing (8-k) 08/08/2017 04:17:34 PM
DRRX News: DURECT Corporation Announces Second Quarter 2017 Financial Results and Provides Corporate Update 08/08/2017 04:05:00 PM
DRRX News: Current Report Filing (8-k) 08/08/2017 12:31:46 PM
PostSubject
#670   There non-opioid pain medication is a game changer, mpp1 08/14/17 02:19:15 PM
#669   zacks realfast95 08/11/17 10:34:19 AM
#668   $PTIE earnings report update on $DRRX product realfast95 08/09/17 01:16:55 PM
#667   Earnings -.07 on rev of 4.3m realfast95 08/08/17 04:40:49 PM
#666   ORADUR®-Methylphenidate ER Capsule Achieves Primary Endpoint in Phase realfast95 08/08/17 09:38:38 AM
#665   DRRX Q2 - Tue Aug 8th 4:30pm est realfast95 08/06/17 02:58:40 PM
#664   Item 1.02. Termination of a Material Definitive Agreement realfast95 08/02/17 05:12:26 PM
#663   should rise steady into cc on 8/7.....keep in dirtydozen911 08/01/17 04:46:31 PM
#662   We expecting a move this week? wagz 08/01/17 04:38:33 PM
#661   Item 1.02. Termination of a Material Definitive Agreement realfast95 07/28/17 04:13:42 PM
#660   IPCI failure to get FDA approval should be realfast95 07/27/17 09:46:16 AM
#659   Progress in Pain Control and Liver Disease Programs realfast95 07/19/17 04:57:06 PM
#658   follow up: Designated status, was given 7/6/17 to realfast95 07/19/17 11:29:39 AM
#657   quite the run. On May 31st it closed realfast95 07/18/17 02:09:56 PM
#656   Put buyers may have placed a short term realfast95 07/16/17 03:49:10 PM
#655   it was just marked 7/6 it's not already realfast95 07/12/17 02:12:09 PM
#654   Doubt they will PR it. It's known already. Youlie 07/12/17 01:44:05 PM
#653   DRRX has not issued a press release on realfast95 07/12/17 01:04:05 PM
#652   That should say Designated status, not approved realfast95 07/12/17 10:14:17 AM
#651   $DRRX (+2.5% pre) DURECT Corp primary sclerosing cholangitis realfast95 07/12/17 07:43:09 AM
#650   Stifel transitions coverage and upgraded Durect Corp (NASDAQ: realfast95 07/12/17 07:41:05 AM
#649   another helpful indicator I found with DRRX. realfast95 07/09/17 03:51:38 PM
#648   Thankyou realfast95. Heard about DRRX from a De302 07/09/17 09:57:08 AM
#647   milestones Q3 complete dosing patients in PERSIST in the realfast95 07/08/17 12:36:44 PM
#646   Hello Realfast95, Have heard some good things De302 07/08/17 12:16:50 PM
#645   the moment of truth 1.62 realfast95 07/07/17 01:08:35 PM
#644   Since the dosage is 3 days long. Why realfast95 06/23/17 12:16:05 PM
#643   DURECT Corp (DRRX): Positive Signs For Posimir - realfast95 06/23/17 09:54:30 AM
#642   DURECT Completes Enrollment in PERSIST, Phase 3 trial nlightn 06/23/17 07:36:59 AM
#641   DRRX @ Stockcharts Investor100 06/21/17 10:13:18 PM
#640   BREAKOUT CONFIRMED breakout above 1.45, no resistance in area realfast95 06/21/17 12:59:39 PM
#639   another run? realfast95 06/19/17 11:47:39 AM
#638   DURECT's Collaboration with Sandoz Clears HSR Review and realfast95 06/19/17 07:07:08 AM
#637   looks like this is getting ready to take dirtydozen911 06/13/17 05:28:40 PM
#636   13 week high, with room to run realfast95 06/01/17 01:50:28 PM
#635   milestones Q2 closing deal - upfront payment to DURECT realfast95 05/19/17 09:29:58 AM
#634   the earnings call on this small Bio was realfast95 05/12/17 10:18:24 AM
#633   sha - BAM realfast95 05/11/17 03:02:08 PM
#632   DURECT Corporation Announces First Quarter 2017 Financial Results nlightn 05/10/17 04:15:05 PM
#631   Durect EPS in-line, beats on revenue nlightn 05/10/17 04:13:24 PM
#630   * * $DRRX Video Chart 05-08-17 * * ClayTrader 05/08/17 04:27:03 PM
#629   Also trading above top BB needs to come stock1ace1 05/08/17 01:23:57 PM
#628   Thats not 293 million upfront .. Read pr stock1ace1 05/08/17 09:52:06 AM
#627   $293M deal and last year revenue was $14M SchlumpyStock-Picker 05/08/17 09:18:42 AM
#626   DURECT and Sandoz have Signed a $293 Million ProfitScout 05/08/17 08:59:00 AM
#625   Durect, Novartis sign $293M U.S. development, marketing deal nlightn 05/08/17 08:16:50 AM
#624   Looking good pre market T695 05/08/17 07:51:37 AM
#623   DURECT Corporation Invites You to Join its First ProfitScout 05/04/17 05:04:34 PM
#622   now thats some very nice news ! this nlightn 04/27/17 10:39:10 PM
#621   The Life Sciences Report Examines How Trial Results ProfitScout 04/27/17 02:42:16 PM
PostSubject